Pitt Hopkins Research Foundation   Report issue

Foundation Phase 2
Founded: Plymouth MA United States (2013)

Organization Overview

First Clinical Trial
2019
NCT04132427
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Pitt Hopkins Research Foundation

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Digestive System Diseases (Phase 2)

Facies (Phase 2)

Gastrointestinal Diseases (Phase 2)

Hyperventilation (Phase 2)

Intellectual Disability (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 3